NanoViricides
NNVC
#10282
Rank
S$25.83 M
Marketcap
S$1.20
Share price
-2.55%
Change (1 day)
-22.09%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of September 2025 : S$9.22 Million

According to NanoViricides's latest financial reports the company has S$9.22 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2025-06-30$S$9.55 M-38.49%
2024-06-30$S$15.53 M-22.73%
2023-06-30$S$20.1 M-37.36%
2022-06-30$S$32.08 M-20.22%
2021-06-30$S$40.22 M32.64%
2020-06-30$S$30.32 M111.61%
2019-06-30$S$14.32 M-40.48%
2018-06-30$S$24.07 M-13.94%
2017-06-30$S$27.97 M-9.9%
2016-06-30$S$31.04 M-27.5%
2015-06-30$S$42.82 M47%
2014-06-30$S$29.13 M186.64%
2013-06-30$S$10.16 M-42.08%
2012-06-30$S$17.54 M40.6%
2011-06-30$S$12.48 M37.89%
2010-06-30$S$9.05 M152.12%
2009-06-30$S$3.59 M494.55%
2008-06-30$S$0.6 M-21.32%
2007-06-30$S$0.76 M-61.06%
2006-06-30$S$1.97 M-1863.72%
2005-06-30$-S$0.12 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
S$29.08 B 315,147.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.72 B 733,896.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$23.79 B 257,834.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$27.63 B 299,401.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-S$0.17 Billion-1,880.61%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.16 Billion-1,760.74%๐Ÿ‡บ๐Ÿ‡ธ USA